Company Filing History:
Years Active: 2023-2024
Title: Marta Pinto: Innovator in Cancer Treatment
Introduction
Marta Pinto is a prominent inventor based in Toulouse, France. She has made significant contributions to the field of cancer treatment through her innovative research and development of RET kinase inhibitors. With a total of 2 patents, her work is paving the way for new therapeutic options for patients.
Latest Patents
Marta Pinto's latest patents focus on RET kinase inhibitors. These patents disclose compounds of formula I, or a pharmaceutically acceptable salt thereof, where the variables are defined within the documentation. These compounds are particularly useful in treating RET associated cancers. Additionally, the patents include formulations containing the compounds of formula I and methods for making these compounds.
Career Highlights
Marta Pinto is currently employed at Eli Lilly and Company, where she continues to advance her research in oncology. Her work is characterized by a commitment to developing effective treatments that can significantly improve patient outcomes.
Collaborations
Marta collaborates with talented coworkers, including Gabrielle R Kolakowski and Erin Danielle Anderson. Together, they contribute to the innovative environment at Eli Lilly and Company, fostering advancements in cancer treatment.
Conclusion
Marta Pinto's contributions to the field of cancer treatment through her patents and collaborations highlight her role as a leading inventor. Her work continues to inspire advancements in medical research and patient care.